Senior insider sale
Chief Executive Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$5.57M
1.54M shares
GIBSON CHRISTOPHER plans to sell 1.54M shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $5.57M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Founders Shares
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/20/2021 | Founders Shares Compensation | 286K | — |
| Total | 286K | ||
Completed
Units to sell
100K
Market value
$368.8K
Units to sell
100K
Market value
$368.8K
Units to sell
100K
Market value
$390.0K
Units to sell
100K
Market value
$390.0K
Units to sell
50K
Market value
$195.0K
Units to sell
100K
Market value
$387.8K
Units to sell
100K
Market value
$378.6K
Units to sell
100K
Market value
$366.6K
Units to sell
340.44K
Market value
$1.09M
Units to sell
40K
Market value
$144.8K
Units to sell
40K
Market value
$123.2K
Units to sell
40K
Market value
$134.8K
Units to sell
40K
Market value
$144.4K
Planned — Approximate Date
Units to sell
286K
Market value
$1.09M
Units
1.54M
Value
$5.57M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2026 | 100K | $368.8K | — | Completed |
7/8/2026 | 100K | $368.8K | — | Completed |
7/7/2026 | 100K | $390.0K | — | Completed |
7/7/2026 | 100K | $390.0K | — | Completed |
7/7/2026 | 50K | $195.0K | — | Completed |
7/6/2026 | 100K | $387.8K | — | Completed |
7/2/2026 | 100K | $378.6K | — | Completed |
7/1/2026 | 100K | $366.6K | — | Completed |
6/18/2026 | 340.44K | $1.09M | — | Completed |
6/5/2026 | 40K | $144.8K | — | Completed |
5/22/2026 | 40K | $123.2K | — | Completed |
5/7/2026 | 40K | $134.8K | — | Completed |
4/22/2026 | 40K | $144.4K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 286K | $1.09M | NASDAQ | Planned |
| Total | 1.54M | $5.57M | ||